BIOL's New Epic 10 Soft Tissue Lasser Will Dramatically Improve Revenue Results Starting In Q4 Period
I'm loading up on BIOL while the stock price awaits a very positive impact from Epic 10 revenue in the Q4 period and with that will come much better bottom line results. Savy investors would be well advised to climb aboard now for an excellent capital gains opportunity.
The BIOL patent protected technology is a paradigm shift for the dental industry and general surgery. Their unique technology allows for Bloodless and painless dental work and surgery. This is a tremendous advance. BIOL has the products on the market now. The table is set.
They have had all this for years! Still have not been able to be profitable. At $6000 a unit they will have to sell a huge number to create a meaningful bump in revenue. Good Luck but don't expect a dramatic change soon of ever.
From a technical perspective BIOL broke above the upper line of the bullish up channel and has now retraced back to touch the upper channel line. This is normal for a breakout--for the price to come down after the breakout to touch the upper line and "kiss it goodbye".